Molecular Therapeutic Approaches for Pediatric Acute Myeloid Leukemia

Approximately two-thirds of children with acute myeloid leukemia (AML) are cured with intensive multi-agent chemotherapy. However, refractory and relapsed AML remains a significant source of childhood cancer mortality, highlighting the need for new therapies. Further therapy intensification with tra...

Descripción completa

Detalles Bibliográficos
Autores principales: Tasian, Sarah K., Pollard, Jessica A., Aplenc, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3957536/
https://www.ncbi.nlm.nih.gov/pubmed/24672775
http://dx.doi.org/10.3389/fonc.2014.00055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3957536/
https://www.ncbi.nlm.nih.gov/pubmed/24672775
http://dx.doi.org/10.3389/fonc.2014.00055

Ejemplares similares